Sun, 05 Dec 2021

The global prenatal testing and newborn screening market is projected to be worth USD 10.85 Billion by 2027, according to a current analysis by Emergen Research. The report throws light on the current economic landscape of this business vertical and evaluates the top market trends. It has been compiled through significant primary research, including surveys, interviews, and expert analysts' observations. The prenatal testing and newborn screening market is observing high demand attributed to its increasing application in detecting fetal chromosome defects. Prenatal testing is considered superior to other screening modalities, particularly for trisomy 21 (one of the most prevalent congenital anomalies).

The Global Prenatal Testing and Newborn Screening Market report provides full coverage of the companies' data, including details about their production and manufacturing capacity, product portfolio, business overview, revenue, gross profit margins, sales network and distribution channel, financial standing, and market position. Prenatal testing enables individuals to make informed decisions as to whether diagnostic testing should be carried out. Associated fetal chromosomal anomalies typically include the benefit or lack of genetic material that can differ from small segments to small segments of chromosomes to entire chromosomes. The increasing popularity among pregnant women as an alternative to amniocentesis and awareness of genetic problems in the fetus and newborn babies drives prenatal testing and newborn screening market.

To get a sample copy of the Global Prenatal Testing and Newborn Screening Market report, visit @ https://www.emergenresearch.com/request-sample/346

Key Highlights From The Report

  • In April 2019, Progenity Inc. made an announcement about the introduction of the Resura Prenatal Test, a non-invasive, personalized prenatal check for monogenetic diseases.
  • Ultrasonography is projected to observe a significant growth rate in the forecast period, owing to the ability of the ultrasound diagnosis to detect anomalies in the position of the baby and actions within the womb.

The Global Prenatal Testing and Newborn Screening Market report presents comprehensive information covering insightful data for businesses and investors for the time period of 2020-2027. The report studies the historical data of the Prenatal Testing and Newborn Screening market and offers valuable information about the key segments and sub-segments, revenue generation, demand and supply scenario, trends, and other vital aspects. The report also studies business strategies and strategic alliances undertaken by companies to gain a robust footing in the market. The report sheds light on the mergers and acquisitions, collaborations, joint ventures, brand promotions and product launches, agreements and partnerships, and corporate and government deals. The comprehensive analysis of the competitive landscape offers the readers a deeper understanding about the competitors.

Top competitors of the Prenatal Testing and Newborn Screening Market profiled in the report include:

  • Abbott Laboratories, Bio-Rad Laboratories, Color Genomics, Edinburgh Genomics, Eurofins Scientific, Agilent Technologies, CRISPR, Illumina Inc., Editas Medicine, and Qiagen NV, among others.

Market Overview:

The research report on the Prenatal Testing and Newborn Screening market is formulated through extensive primary and secondary research along with qualitative and quantitative analysis of vital aspects of the market. The insightful data is further validated and verified by the industry professionals. The report strives to offer deeper insights into the overall market scenario of the Prenatal Testing and Newborn Screening business sphere.

To learn more details about the Global Prenatal Testing and Newborn Screening Market report, visit @ https://www.emergenresearch.com/industry-report/prenatal-testing-and-newborn-screening-market:

The report aims to deliver a comprehensive understanding of the Prenatal Testing and Newborn Screening market growth and expansion in each key region of the world. It offers accurate estimations about the expected market size and growth over the projected timeline of 2020-2027.

Emergen Research has segmented the global prenatal testing and newborn screening market on the basis of type, test type, technology, instrument, end-users, and region:

  • Type Outlook (Revenue, USD Billion; 2017-2027)
    • Prenatal Testing
    • Newborn Screening
  • Test Type Outlook (Revenue, USD Billion; 2017-2027)
    • Non-Invasive
    • Invasive
  • Technology Outlook (Revenue, USD Billion; 2017-2027)
    • Mass Spectrometry
    • Electrophoresis
    • Enzyme Immunoassays
    • DNA Assays
  • Instrument Outlook (Revenue, USD Billion; 2017-2027)
    • Ultrasonography
    • Reagent and Assay Kits
    • Tandem Quadrupole Detector
    • Incubator Shaker
    • Hearing Screen Instruments
  • End Users Outlook (Revenue, USD Billion; 2017-2027)
    • Hospitals
    • Maternity & Specialty Clinics
    • Diagnostic Centers

Regional Outlook:

The report offers a comprehensive analysis of the current growth opportunities for various regions of the Prenatal Testing and Newborn Screening market. It gauges the revenue shares of these regions over the forecast timeline. Furthermore, the report analyzes the year-on-year growth rate of these regions over the forecast duration. The leading geographic regions encompassed in the report include North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Proceed To Buy: https://www.emergenresearch.com/select-license/346

Table of Content

Chapter 1. Methodology & Sources

1.1. Nanopharmaceutical Drugs Market Definition

1.2. Research Scope

1.3. Methodology

1.4. Research Sources

1.5. Nanopharmaceutical Drugs Market Estimation Technique

Chapter 2. Executive Summary

2.1. Summary Snapshot, 2021-2028

Chapter 3. Key Insights

Chapter 4. Nanopharmaceutical Drugs Market Segmentation & Impact Analysis

4.1. Nanopharmaceutical Drugs Market Material Segmentation Analysis

4.2. Industrial Outlook

4.2.1. Nanopharmaceutical Drugs Market indicators analysis

4.2.2. Nanopharmaceutical Drugs Market drivers analysis

4.2.2.1. Rapid urbanization and industrialization

4.2.2.2. Stringent government regulations regarding carbon emissions

4.2.2.3. Increasing prevalence of respiratory diseases

4.2.2.4. Rising need to enhance indoor air quality

4.2.3. Nanopharmaceutical Drugs Market restraints analysis

4.2.3.1. High cost associated with the maintenance of Nanopharmaceutical Drugs products

4.2.3.2. Availability of renewable sources of energy

4.3. Technological Insights

4.4. Regulatory Framework

4.5. Porter's Five Forces Analysis

4.6. Competitive Metric Space Analysis

4.7. Price trend Analysis

4.8. Covid-19 Impact Analysis

Continued….

Key Benefits of Buying the Global Prenatal Testing and Newborn Screening Report:

  • Comprehensive analysis of the changing competitive landscape
  • Assists in decision making processes for the businesses along with detailed strategic planning methodologies
  • The report offers an 8-year forecast and assessment of the Global Prenatal Testing and Newborn Screening Market
  • Helps in understanding the key product segments and their estimated growth rate
  • In-depth analysis of market drivers, restraints, trends, and opportunities
  • Comprehensive regional analysis of the Global Prenatal Testing and Newborn Screening Market

Request customization of the report: https://www.emergenresearch.com/request-for-customization/346

Thank you for reading our report. If you have any requests for customization of the latest report, kindly get in touch with us. Our team will assist you and ensure the report is designed as per your requirements.

Read similar reports by Emergen Research:

In-Vitro Fertilization Market: https://www.emergenresearch.com/industry-report/in-vitro-fertilization-market

Newborn Screening Market: https://www.emergenresearch.com/industry-report/new-born-screening-market

RFID in Healthcare Market: https://www.emergenresearch.com/industry-report/rfid-in-healthcare-market

Next-Generation Sequencing Market: https://www.emergenresearch.com/industry-report/next-generation-sequencing-market

Regenerative Medicine Market: https://www.emergenresearch.com/industry-report/regenerative-medicine-market

About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkedIn | Twitter | Blogs

More United States News

Access More

Sign up for United States News

a daily newsletter full of things to discuss over drinks.and the great thing is that it's on the house!